Euclidean Technologies Management, LLC Moderna, Inc. Transaction History

Euclidean Technologies Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$118.38 - $210.04 $147,501 - $261,709	1,246 New	1,246 $223,000
Q2 2022 Jul 25, 2022	SELL	$117.13 - $176.59 $145,943 - $220,031	-1,246 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$126.46 - $235.05 $157,569 - $292,872	1,246 New	1,246 $215,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Euclidean Technologies Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Euclidean Technologies Management, LLC with notifications on news.